Stock Monitor: Joint Corp. Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 06, 2017 / Active-Investors free earnings report on HCA Healthcare, Inc. (NYSE: HCA) has freshly been issued to its members, and you can also sign up to view this report at www.active-investors.com/registration-sg/?symbol=HCA. The Company reported its third quarter fiscal 2017 operating results on October 31, 2017. The hospital operator's revenue grew 4.2% on a y-o-y basis. Register today and get free access to our complimentary member's area where many more reports are available:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for The Joint Corp. (NASDAQ: JYNT), which also belongs to the Healthcare sector as the Company HCA Healthcare. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=JYNT

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, HCA Healthcare most recent news is on our radar and we have decided to include it on our blog post. Today's free coverage is available at:

www.active-investors.com/registration-sg/?symbol=HCA

Earnings Highlights and Summary

HCA Healthcare's revenues increased 4% to $10.70 billion in Q3 2017 compared to $10.27 billion in Q3 2016, topping analysts' estimates of $10.67 billion. The Company noted that the hospitals acquired during 2017 contributed approximately $155 million to the increase in revenues in the reported quarter.

During Q3 2017, net income attributable to HCA Healthcare totaled $426 million, or $1.15 per diluted share, compared to $618 million, or $1.59 per diluted share, in Q3 2016. The Company recognized tax benefits of $0.01 per diluted share, and $0.03 per diluted share, for Q3 2017 and 2016, respectively, related to excess tax benefits for employee equity award settlements.

HCA Healthcare's results for Q3 2017 also included gains on sales of facilities of $0.01 per diluted share, and losses on retirement of debt of $0.07 per diluted share. The Company's results for Q3 2016 included gains on sales of facilities of $0.01 per diluted share, losses on retirement of debt of $0.01 per diluted share, and legal claim costs of $0.02 per diluted share. The Company recognized a reduction in the provision for income taxes of $51 million, or $0.13 per diluted share, during Q3 2016, resulting from the completion of the IRS examination of HCA Healthcare's 2011 and 2012 federal income tax returns. On an adjusted basis, HCA Healthcare reported earnings of $1.21 per diluted share compared to $1.61 per diluted share in Q3 2016, meeting Wall Street's expectations of $1.21 per share.

Operating Results

During Q3 2017, HCA Healthcare's same facility equivalent admissions increased 0.3% on y-o-y basis, while its same facility admissions grew 0.6%. The Company's same facility emergency room visits increased 0.3% in the reported quarter. HCA Healthcare estimated that hurricanes had unfavorable impacts of 80 basis points on same facility equivalent admissions growth, 30 basis points on same facility admissions growth, and 30 basis points on same facility emergency visits growth during the reported quarter.

During Q3 2017, HCA Healthcare's same facility inpatient surgeries declined 0.7%, while same facility outpatient surgeries declined 4.2% on a y-o-y basis. The Company's same facility revenue per equivalent admission increased 2.0% in the reported quarter.

For Q3 2017, HCA Healthcare's salaries and benefits, supplies, and other operating expenses totaled $8.933 billion, or 83.5% of revenues, compared to $8.335 billion, or 81.1% of revenues, in Q3 2016.

During Q3 2017, HCA Healthcare's same facility Medicare admissions comprised 45.5% of the Company's overall admissions, while its same facility managed care and exchange admissions were 27.2% of total admissions compared to 44.7% and 27.8%, respectively, in Q3 2016.

As of September 30, 2017, HCA Healthcare operated 177 hospitals and 119 freestanding surgery centers.

Balance Sheet and Cash Flows from Operations

As of September 30, 2017, HCA Healthcare's balance sheet reflected cash and cash equivalents of $718 million, total debt of $32.953 billion, and total assets of $35.731 billion. During Q3 2017, the Company's capital expenditure totaled $729 million, excluding acquisitions.

HCA Healthcare's cash flows provided by operating activities totaled $1.01 billion in Q3 2017 compared to $1.21 billion in Q3 2016. The decline in cash flow was primarily attributed to the $215 million decline in net income.

As of September 30, 2017, HCA's leverage ratio, as measured by Total Debt/Adjusted EBITDA, was 4.08x compared to 3.82x as of December 31, 2016. During Q3 2017, HCA Healthcare repurchased 6.3 million shares of its common stock at a cost of $509 million.

Stock Performance Snapshot

December 05, 2017 - At Tuesday's closing bell, HCA Healthcare's stock declined 1.25%, ending the trading session at $83.22.

Volume traded for the day: 2.50 million shares.

Stock performance in the last month ? up 8.88%; previous three-month period ? up 7.69%; past twelve-month period ? up 17.91%; and year-to-date ? up 12.43%

After yesterday's close, HCA Healthcare's market cap was at $28.34 billion.

Price to Earnings (P/E) ratio was at 11.84.

The stock is part of the Healthcare sector, categorized under the Hospitals industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors